SMARCA4 and neoplasm of thorax: SMARCA4-deficient non-small cell lung cancer (NSCLC) is an uncommon primary malignant epithelial tumor originating in the lung, classified as a distinct clinicopathologic entity in the World Health Organization Classification of Thoracic Tumors, published in May 2021.